Default: Nature Reviews Endocrinology

ISSN: 1759-5029

Journal Home

Journal Guideline

Nature Reviews Endocrinology Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Endocrinology is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 203. It has an SJR impact factor of 7,274 and it has a best quartile of Q1. It has an SJR impact factor of 7,274.

Nature Reviews Endocrinology focuses its scope in these topics and keywords: insulin, glucose, exercise, health, lipid, marrow, metabolic, gut, d, diabetes, ...

Type: Journal

Type of Copyright:


Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

- €

Non OA


Nature Reviews Endocrinology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Other journals with similar parameters

Endocrine Reviews Q1
Nature Metabolism Q1
Diabetes Care Q1
Bone Research Q1
Diabetologia Q1

Compare this journals

Aims and Scope

insulin, glucose, exercise, health, lipid, marrow, metabolic, gut, d, diabetes, clock, code, approachadvances, crossroads, dcontrolling, deficiencies, development, clinical, characteristicsgut, challengeece, acth, activityendocannabinoids, adenomas, agonists, bat, bazedoxifenemicronutrient, benefits, bone, cancer, cardiovascular,

Best articles by citations

Malformation syndromes associated with disorders of sex development

View more

Can inflammatory status define metabolic health?

View more

Gut-specific FXR agonism

View more

Late to bed, late to rise, could be cardiometabolically unwise

View more

Does celiac disease trigger autoimmune thyroiditis?

View more

Should we screen for emotional distress in type 2 diabetes mellitus?

View more

Safety and efficacy of albiglutide - results from two trials

View more

Balancing BMI - rethinking the relationships between obesity, ageing and risk of dementia

View more

Hypertension in obesity: the role of hypothalamic inflammation

View more

Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism

View more

Postablative thyroglobulin levels predict recurrence of thyroid cancer

View more

A conundrum addressed: the prognostic value of HbA1c

View more

Testosterone replacement therapy improves the metabolic syndrome

View more

Outcomes of diabetes mellitus in Asian Americans

View more

Not so sweet - artificial sweeteners can cause glucose intolerance by affecting the gut microbiota

View more

Impact loading - nature's way to strengthen bone

View more

Epigenetic changes lead to impaired wound healing in patients with T2DM

View more

T2DM - PPAR gamma ligands without the adverse effects?

View more

Formation of blood vessels in bone maturation and regeneration

View more

Predictors of metabolic outcome after surgery for adrenal incidentaloma

View more

Reversing the tide - diagnosis and prevention of T2DM in populations of African descent

View more

Osteopontin to determine response to parathyroid hormone therapy?

View more

ILC2s regulate obesity and drive beiging of white adipose tissue

View more

A role for CFTR in beta-cell function

View more